Home / Private raises / Janus Henderson Biotech Innovation Fund II Access LLC

Janus Henderson Biotech Innovation Fund II Access LLC

Hedge Fund · New York, New York · $155M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-10-13D/A (update)$155MOpen-ended610506(b), 3(c), 3(c)(7)Equity, Fund interestsSep 1SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Sold through (placement agents)

No sales commission reported in the latest filing.

Issuer

IndustryPooled Investment Fund
Fund typeHedge Fund
LocatedNew York, New York
EntityLimited Liability Company
IncorporatedDelaware, 2025
SEC CIK2085092

People named in the latest filing

NameRole
- Asterion Fund Services, L.L.C.Manager of the Issuer
- Maples Fiduciary Services (Delaware) Inc.Managing Member of the Manager of the Issuer ("MFSD Inc.")
- iCapital Alternative Investments LLCAdministrator of the Issuer
Coleen GasiewskiExecutive Officer
Scott HuffExecutive Officer
Max SchwartzAuthorized Signatory of the Administrator of the Issuer

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?